assessed serum irisin for distinguishing heart failure phenotypes in diabetic patients, finding that while certain biomarkers improved phenotype‐specific predictions, the static nature of ROC‐based cutoffs limited broader applicability [26]. The gene discussed is FNDC5; the disease is heart failure.